BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 34150029)

  • 1. Next generation sequencing of glioblastoma circulating tumor cells: non-invasive solution for disease monitoring.
    Kolostova K; Pospisilova E; Pavlickova V; Bartos R; Sames M; Pawlak I; Bobek V
    Am J Transl Res; 2021; 13(5):4489-4499. PubMed ID: 34150029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-Free DNA Variant Sequencing Using CTC-Depleted Blood for Comprehensive Liquid Biopsy Testing in Metastatic Breast Cancer.
    Keup C; Storbeck M; Hauch S; Hahn P; Sprenger-Haussels M; Tewes M; Mach P; Hoffmann O; Kimmig R; Kasimir-Bauer S
    Cancers (Basel); 2019 Feb; 11(2):. PubMed ID: 30781720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation Between Circulating Tumor Cell DNA Genomic Alterations and Mesenchymal CTCs or CTC-Associated White Blood Cell Clusters in Hepatocellular Carcinoma.
    Wang C; Luo Q; Huang W; Zhang C; Liao H; Chen K; Pan M
    Front Oncol; 2021; 11():686365. PubMed ID: 34178679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutational analysis of single circulating tumor cells by next generation sequencing in metastatic breast cancer.
    De Luca F; Rotunno G; Salvianti F; Galardi F; Pestrin M; Gabellini S; Simi L; Mancini I; Vannucchi AM; Pazzagli M; Di Leo A; Pinzani P
    Oncotarget; 2016 May; 7(18):26107-19. PubMed ID: 27034166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection and cultivation of circulating tumor cells in gastric cancer.
    Kolostova K; Matkowski R; Gürlich R; Grabowski K; Soter K; Lischke R; Schützner J; Bobek V
    Cytotechnology; 2016 Aug; 68(4):1095-102. PubMed ID: 25862542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Next-generation Sequencing (NGS) Analysis on Single Circulating Tumor Cells (CTCs) with No Need of Whole-genome Amplification (WGA).
    Palmirotta R; Lovero D; Silvestris E; Felici C; Quaresmini D; Cafforio P; Silvestris F
    Cancer Genomics Proteomics; 2017; 14(3):173-179. PubMed ID: 28446532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of a novel circulating tumor DNA next-generating sequencing platform with circulating tumor cells (CTCs) and CTC clusters in metastatic breast cancer.
    Davis AA; Zhang Q; Gerratana L; Shah AN; Zhan Y; Qiang W; Finkelman BS; Flaum L; Behdad A; Gradishar WJ; Platanias LC; Cristofanilli M
    Breast Cancer Res; 2019 Dec; 21(1):137. PubMed ID: 31801599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneity of PIK3CA mutational status at the single cell level in circulating tumor cells from metastatic breast cancer patients.
    Pestrin M; Salvianti F; Galardi F; De Luca F; Turner N; Malorni L; Pazzagli M; Di Leo A; Pinzani P
    Mol Oncol; 2015 Apr; 9(4):749-57. PubMed ID: 25539732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative Mutational Analysis of Circulating Tumor Cells (CTCs) and Plasma-cfDNA Provides Complementary Information for Early Prediction of Relapse: A Pilot Study in Early-Stage Non-Small Cell Lung Cancer.
    Markou AN; Londra D; Stergiopoulou D; Vamvakaris I; Potaris K; Pateras IS; Kotsakis A; Georgoulias V; Lianidou E
    Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Innovative Approach to Isolate and Characterize Glioblastoma Circulating Tumor Cells and Correlation with Tumor Mutational Status.
    Lessi F; Morelli M; Franceschi S; Aretini P; Menicagli M; Marranci A; Pasqualetti F; Gambacciani C; Pieri F; Grimod G; Zucchi V; Cupini S; Di Stefano AL; Santonocito OS; Mazzanti CM
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic Characterization of Cancer of Unknown Primary Using Liquid Biopsy Approaches.
    Laprovitera N; Salamon I; Gelsomino F; Porcellini E; Riefolo M; Garonzi M; Tononi P; Valente S; Sabbioni S; Fontana F; Manaresi N; D'Errico A; Pantaleo MA; Ardizzoni A; Ferracin M
    Front Cell Dev Biol; 2021; 9():666156. PubMed ID: 34178989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating tumor cells in localized prostate cancer: isolation, cultivation in vitro and relationship to T-stage and Gleason score.
    Kolostova K; Broul M; Schraml J; Cegan M; Matkowski R; Fiutowski M; Bobek V
    Anticancer Res; 2014 Jul; 34(7):3641-6. PubMed ID: 24982381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of isolated circulating tumor cells and tissue biopsies using whole-genome sequencing in prostate cancer.
    Jiang R; Lu YT; Ho H; Li B; Chen JF; Lin M; Li F; Wu K; Wu H; Lichterman J; Wan H; Lu CL; OuYang W; Ni M; Wang L; Li G; Lee T; Zhang X; Yang J; Rettig M; Chung LW; Yang H; Li KC; Hou Y; Tseng HR; Hou S; Xu X; Wang J; Posadas EM
    Oncotarget; 2015 Dec; 6(42):44781-93. PubMed ID: 26575023
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Mastoraki S; Strati A; Tzanikou E; Chimonidou M; Politaki E; Voutsina A; Psyrri A; Georgoulias V; Lianidou E
    Clin Cancer Res; 2018 Mar; 24(6):1500-1510. PubMed ID: 29284708
    [No Abstract]   [Full Text] [Related]  

  • 15. Mutational analysis of circulating tumor cells from colorectal cancer patients and correlation with primary tumor tissue.
    Lyberopoulou A; Aravantinos G; Efstathopoulos EP; Nikiteas N; Bouziotis P; Isaakidou A; Papalois A; Marinos E; Gazouli M
    PLoS One; 2015; 10(4):e0123902. PubMed ID: 25902072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation of Circulating Tumour Cells in Patients With Glioblastoma Using Spiral Microfluidic Technology - A Pilot Study.
    Müller Bark J; Kulasinghe A; Hartel G; Leo P; Warkiani ME; Jeffree RL; Chua B; Day BW; Punyadeera C
    Front Oncol; 2021; 11():681130. PubMed ID: 34150645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosomal Instability Estimation Based on Next Generation Sequencing and Single Cell Genome Wide Copy Number Variation Analysis.
    Greene SB; Dago AE; Leitz LJ; Wang Y; Lee J; Werner SL; Gendreau S; Patel P; Jia S; Zhang L; Tucker EK; Malchiodi M; Graf RP; Dittamore R; Marrinucci D; Landers M
    PLoS One; 2016; 11(11):e0165089. PubMed ID: 27851748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Workflow optimization of whole genome amplification and targeted panel sequencing for CTC mutation detection.
    Liu HE; Triboulet M; Zia A; Vuppalapaty M; Kidess-Sigal E; Coller J; Natu VS; Shokoohi V; Che J; Renier C; Chan NH; Hanft VR; Jeffrey SS; Sollier-Christen E
    NPJ Genom Med; 2017; 2():34. PubMed ID: 29263843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer gene panel analysis of cultured circulating tumor cells and primary tumor tissue from patients with breast cancer.
    Hwang E; Uh JH; Lee HS; Lee CH; Lee SJ; Ahn SH; Son BH; Lee JW; Yu JH; Kwon NJ; Lee WC; Yang KS; Choi SH; Kim MS; Lee J; Jeon BH
    Oncol Lett; 2017 Jun; 13(6):4627-4632. PubMed ID: 28599463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Cross-Sectional Comparison of Druggable Mutations in Primary Tumors, Metastatic Tissue, Circulating Tumor Cells, and Cell-Free Circulating DNA in Patients with Metastatic Breast Cancer: The MIRROR Study Protocol.
    Gonzalez-Rivera M; Picornell AC; Alvarez EL; Martin M
    JMIR Res Protoc; 2016 Aug; 5(3):e167. PubMed ID: 27531554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.